Hydrodilatation in adhesive capsulitis, Intra-articular corticosteroid in adhesive capsulitis

Phase 3

• Conditions: Shoulder adhesive capsulitis.; Adhesive capsulitis of unspecified shoulder; M75.00

• Registration Number: IRCT20210910052428N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

Presence of pain and shoulder range of motion limitation more than 30 degree in more than two motion plane
Presence of pain and shoulder range of motion limitation more than one month

Exclusion Criteria

Shoulder pain after cerebrovascular attack in paretic side
Patients with severe glenohumeral joint osteoarthritis
Patients with complete rotator cuff ligaments tear
Immune deficiency
Fracture in humerus bone or scapula
Pregnant women
Patients with cancer
History of allergy and reaction due in use drugs
Shoulder joint rheumatoid arthritis
Severe depression
Uncontrolled diabetes

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Score of pain in visual analoge scale questionnaire , Shoulder disability score in shoulder pain and disability index questionnaire. Timepoint: Measurement of shoulder range of motion and pain score at the beginning, 2, 4 and 8 weeks after shoulder injection. Method of measurement: Visual analog scale and shoulder pain and disability index.

Secondary Outcome Measures

Name	Time	Method
Shoulder Pain. Timepoint: Before intervention; two weeks, four weeks and eight weeks later. Method of measurement: Visual Analogue Scale; Shoulder Pain And Disability Index.;Shoulder range of motion. Timepoint: Before intervention; two weeks, four weeks and eight weeks later. Method of measurement: With usage of goniometer.